ArticleFrontiers in immunology2025

EGR3 as a dual tumor-immune regulator: a machine learning-driven prognostic target for cold breast cancer.

Qianxue Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.